This editorial status is separate from the existing medical-review attribution shown above.
A headline price is useful only when its product category, supply period, upfront commitment, and eligibility rule are clear.
Luma lists compounded injectable semaglutide at $120/month and compounded injectable tirzepatide at $165/month. NovoCare and LillyDirect publish distinct self-pay routes for FDA-approved Wegovy and Zepbound. A clinician—not this comparison—decides whether any medication or formulation is appropriate.[1] [5] [8]
Commercial disclosure: Luma Health offers compounded semaglutide and compounded tirzepatide, competes in this category, and may benefit if a reader chooses Luma. This is a source-dated comparison of public terms, not an independent ranking, medical recommendation, price quote, or guarantee of prescription, availability, coverage, delivery, or outcome.
Product category comes before the ingredient name
Wegovy and Zepbound are FDA-approved branded finished drugs. Luma describes its injectable options as compounded semaglutide and compounded tirzepatide. A compounded preparation is not an FDA-approved brand-name drug, a generic version of Wegovy or Zepbound, or an interchangeable product. FDA says compounded drugs are not reviewed for safety, effectiveness, or quality before marketing and should not be promoted as the same as, or clinically proven to have the same result as, an approved drug.[11] [12]
The figures below compare stated access terms, not clinical value or expected results. They do not transfer branded-product evidence to a compounded preparation.
September 22 price snapshot: match each price to its unit
| Route and category | Published price | Essential term |
|---|---|---|
| Luma compounded injectable semaglutide | $120/month | Month-to-month billing; no minimum commitment stated. Luma lists consultation, prescription if appropriate, medication, and shipping as included.[1] |
| Luma compounded injectable tirzepatide | $165/month | Month-to-month billing; no minimum commitment stated. The same listed inclusions and prescription qualification apply.[1] |
| NovoCare Wegovy injection | $199 per 28-day fill | Eligible new patients’ first two 0.25 mg or 0.5 mg fills only; redemption and fill by December 31, 2026.[5] [6] |
| NovoCare Wegovy injection | $349 per 28-day fill | Current standard self-pay offer at 0.25–2.4 mg; a fill is four single-dose pens. Wegovy HD 7.2 mg is $399 per fill.[5] [6] |
| LillyDirect Zepbound | $299 / $399 per 28 days | Starting self-pay price at 2.5 mg / 5 mg. A month is four vials or one KwikPen; separate supplies, taxes, and fees may apply.[8] [9] |
| LillyDirect Journey offer | $449 per 28 days | For 7.5–15 mg when the offer applies. A qualifying refill must be bought within 45 days of prior delivery or receipt; otherwise regular prices apply.[8] [9] |
Luma’s monthly plans use a monthly billing interval, while its prepaid choices require an upfront total. NovoCare and LillyDirect define the branded injection comparison unit as 28 days. This is a comparison of published units, not a treatment schedule.
Luma: monthly billing versus a prepaid total
Luma also lists prepaid options: $240 total for three months or $470 total for six months of compounded injectable semaglutide, and $450 total or $880 total for compounded injectable tirzepatide. The full total is due if prescribed. The displayed $80, $78, $150, and $147 figures are monthly equivalents, not monthly installment amounts. No public 12-month dollar total was verified.[1]
To show the commitment rather than recommend a plan, six $120 monthly semaglutide charges equal $720; the stated six-month prepaid total is $470 upfront. Six $165 monthly tirzepatide charges equal $990; the stated six-month prepaid total is $880 upfront. The arithmetic excludes any unverified expense and does not establish refundability, availability, or future pricing.
Luma says standard shipping is free and gives a 2–3-business-day estimate, not a guarantee. Legal service area, treatment, provider, pharmacy, product availability, and delivery circumstances can affect fulfillment.[4]
Luma billing is part of the total-cost comparison
Luma says subscriptions automatically renew unless cancelled or paused. To stop an upcoming bill, a cancellation or pause request must be submitted at least 15 days before the next scheduled billing date. A later request cannot be guaranteed to stop the upcoming bill or associated auto-refill. Luma says all sales are final and no refunds are provided; cancellation does not reverse a properly processed charge.[2] [3]
Medication ships on a monthly or quarterly schedule, depending on the selected treatment plan. Shipment cadence is separate from the payment amount and billing interval, which are disclosed at checkout. Do not assume a prepaid total creates monthly installments or removes automatic renewal.[1] [2] [3]
Before purchase, review the full order total and every listed service charge rather than assuming that an advertised medication price describes every possible arrangement.
Wegovy: $199 is a narrow introductory price
NovoCare separates Wegovy injection from Wegovy tablets; this injection comparison does not borrow tablet pricing. A Wegovy injection month is four single-dose pens, or 28 days. The $199 price applies only to eligible new patients’ first two 28-day fills at 0.25 mg or 0.5 mg. A new patient is new to the Wegovy Savings Offer and has not participated in another Wegovy Savings Offer in the prior 365 days. The offer must be redeemed and the prescription filled by December 31, 2026.[5] [6]
NovoCare’s stated standard self-pay offer is $349 per 28-day fill at 0.25–2.4 mg and $399 for Wegovy HD 7.2 mg. Six $349 fills total $2,094; six $399 fills total $2,394. Two qualifying $199 fills plus four $349 fills total $1,794. This is only six-fill arithmetic: it assumes unchanged terms, eligibility, and dispensing, and does not predict a dose, coverage result, or total health-care spending.[5] [6]
Self-pay operates outside third-party insurance. It cannot be submitted for reimbursement or counted toward a deductible or out-of-pocket maximum. The separate commercial-insurance “as little as $25” claim is not an uninsured price. The $149 4 mg tablet promotion expired August 31, 2026 and is not a current injection offer.[5] [7]
Zepbound: $449 at higher doses has a timing condition
LillyDirect lists both four single-dose vials and one single-patient-use KwikPen as 28-day Zepbound supplies. Its self-pay prices start at $299 for 2.5 mg and $399 for 5 mg. Vials require separately purchased needles and syringes; KwikPens require separately purchased pen needles. Taxes and fees may apply.[8] [9]
At 7.5 mg, 10 mg, 12.5 mg, and 15 mg, $449 is a conditional Journey purchase offer. The first qualifying purchase receives it; continued eligibility requires buying the refill within 45 days of the previous delivery or receipt. When that condition is missed, Lilly lists regular prices of $499 at 7.5 mg and $699 at 10–15 mg. Six purchases at $449 total $2,694 only if the condition applies each time. Offers may change and are separate from commercial-insurance savings pathways.[8] [9] [10]
Four questions before comparing an affordability claim
What is the finished-product category?
Record FDA-approved branded product or compounded preparation before comparing the price.
What is due today?
Separate a 28-day fill, monthly bill, and prepaid total from any displayed monthly equivalent.
Which condition makes the price available?
Note offer deadlines, eligibility, refill timing, supplies, taxes, fees, renewal, and cancellation rules.
Who decides the clinical question?
NIDDK says medication choice considers benefits, side effects, health issues, other medicines, family history, and cost. Prescription medicines do not replace healthy eating and physical activity.[13]
Commercial disclosure: Luma Health offers compounded options and may benefit if a reader chooses Luma.
Review the full terms,
not only a headline price.
Check current pricing, billing terms, and checkout disclosure. A licensed clinician determines whether prescription treatment is appropriate.
Start an Online Visit →Review Luma PricingFrequently asked questions
No. The public page lists $240 or $470 totals for three or six months of compounded semaglutide and $450 or $880 totals for compounded tirzepatide. The plan total is due in full if prescribed.[1]
References
- Luma Health. Transparent Pricing. Full first-party page read September 22, 2026.
- Luma Health. Billing Terms & Conditions. Full first-party page read September 22, 2026.
- Luma Health. Auto-Refill & Cancellation Policy. Full first-party page read September 22, 2026.
- Luma Health. Shipping Policy. Full first-party page read September 22, 2026.
- Novo Nordisk. Terms and conditions of use — Wegovy Savings Offer. Full first-party terms read September 22, 2026.
- NovoCare. Wegovy® (semaglutide) Online Pharmacy. Full first-party page read September 22, 2026.
- NovoCare. Savings Offer Program for Wegovy® (semaglutide). Full first-party page read September 22, 2026.
- Eli Lilly and Company. Authentic Zepbound (tirzepatide) Shipped to You. Full first-party page read September 22, 2026.
- Eli Lilly and Company. Zepbound (tirzepatide): Full Terms and Conditions. Full first-party terms read September 22, 2026.
- Eli Lilly and Company. Zepbound Cost Information | With or Without Insurance. Full first-party page read September 22, 2026.
- U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Full page read September 22, 2026.
- U.S. Food and Drug Administration. FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs. Full page read September 22, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity. Full page read September 22, 2026.